BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+8.25%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$2.1B
AUM Growth
+$2.1B
(+8.5%)
Cap. Flow
+$301M
Cap. Flow
% of AUM
14.32%
Top 10 Holdings %
Top 10 Hldgs %
81.04%
Holding
26
New
2
Increased
14
Reduced
2
Closed
2
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$175M |
| 2 |
RDUS
Radius Health, Inc.
RDUS
|
$35.7M |
| 3 |
Puma Biotechnology
PBYI
|
$30.3M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$23.2M |
| 5 |
Ionis Pharmaceuticals
IONS
|
$14M |
Top Sells
| 1 |
IDIX
IDENIX PHARMACEUTICALS INC
IDIX
|
$7.54M |
| 2 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$4.35M |
| 3 |
Gilead Sciences
GILD
|
$2.07M |
| 4 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$1.38M |
Sector Composition
| 1 | Healthcare | 85.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $362M | 17.22% | 4,219,298 +2,034,649 | +93% | +$175M |
|
|
2
Gilead Sciences
GILD
$140B
| $289M | 13.74% | 3,488,496 -25,000 | -0.7% | -$2.07M |
|
3
Incyte
INCY
$16.5B
| $235M | 11.17% | 4,163,790 +30,000 | +0.7% | +$1.69M |
|
|
4
Ionis Pharmaceuticals
IONS
$6.79B
| $231M | 10.98% | 6,706,526 +405,000 | +6% | +$14M |
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $133M | 6.32% | 1,404,445 | – | – |
|
|
MDVN
6
DELISTED
MEDIVATION, INC.
MDVN
| $116M | 5.49% | 1,499,706 +40,000 | +3% | +$3.08M |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $114M | 5.4% | 727,428 | – | – |
|
|
GEVA
8
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $94.2M | 4.47% | 898,476 -41,481 | -4% | -$4.35M |
|
9
Regeneron Pharmaceuticals
REGN
$61.5B
| $65.8M | 3.13% | 233,000 +10,000 | +4% | +$2.82M |
|
|
PCYC
10
DELISTED
PHARMACYCLICS INC
PCYC
| $65.6M | 3.12% | 731,542 +95,000 | +15% | +$8.52M |
|
11
Halozyme
HALO
$8.56B
| $57.8M | 2.74% | 5,846,564 +205,000 | +4% | +$2.03M |
|
12
Neurocrine Biosciences
NBIX
$13.8B
| $45.8M | 2.18% | 3,086,552 +90,000 | +3% | +$1.34M |
|
13
Alnylam Pharmaceuticals
ALNY
$58.5B
| $39.2M | 1.86% | 621,288 +150,000 | +32% | +$9.48M |
|
|
14
Puma Biotechnology
PBYI
$254M
| $38.1M | 1.81% | 576,991 +459,000 | +389% | +$30.3M |
|
|
IMGN
15
DELISTED
Immunogen Inc
IMGN
| $37.5M | 1.78% | 3,165,816 | – | – |
|
|
RDUS
16
DELISTED
Radius Health, Inc.
RDUS
| $35.7M | 1.7% | +2,745,040 | New | +$35.7M |
|
17
Innoviva
INVA
$1.29B
| $27.8M | 1.32% | 933,244 +45,000 | +5% | +$1.34M |
|
|
18
Agios Pharmaceuticals
AGIO
$2.19B
| $23.2M | 1.1% | +506,000 | New | +$23.2M |
|
|
CLVS
19
DELISTED
Clovis Oncology, Inc.
CLVS
| $23.1M | 1.1% | 558,188 +70,000 | +14% | +$2.9M |
|
|
TSRO
20
DELISTED
TESARO, Inc.
TSRO
| $21.9M | 1.04% | 704,582 +100,000 | +17% | +$3.11M |
|
|
INFI
21
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $19.2M | 0.91% | 1,505,737 +205,000 | +16% | +$2.61M |
|
|
ECYT
22
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $16.2M | 0.77% | 2,463,522 | – | – |
|
|
ACHN
23
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $13.5M | 0.64% | 1,779,340 | – | – |
|
|
ARIA
24
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| – | – | -171,517 | Closed | -$1.38M |
|
|
IDIX
25
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
| – | – | -1,250,000 | Closed | -$7.54M |
|